PHAROL SGPS SA (PHR.LS) Fundamental Analysis & Valuation

ELI:PHR • PTPTC0AM0009

Current stock price

0.0778 EUR
+0 (+0.65%)
Last:

This PHR.LS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PHR.LS Profitability Analysis

1.1 Basic Checks

  • In the past year PHR has reported negative net income.
  • In the past year PHR has reported a negative cash flow from operations.
  • In the past 5 years PHR reported 4 times negative net income.
  • In the past 5 years PHR reported 4 times negative operating cash flow.
PHR.LS Yearly Net Income VS EBIT VS OCF VS FCFPHR.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M -800M

1.2 Ratios

  • With a Return On Assets value of 1.75%, PHR perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
  • PHR has a Return On Equity (1.78%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.75%
ROE 1.78%
ROIC N/A
ROA(3y)7.12%
ROA(5y)2.27%
ROE(3y)7%
ROE(5y)1.96%
ROIC(3y)N/A
ROIC(5y)N/A
PHR.LS Yearly ROA, ROE, ROICPHR.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200 -300

1.3 Margins

  • PHR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHR.LS Yearly Profit, Operating, Gross MarginsPHR.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024

7

2. PHR.LS Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for PHR remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for PHR remains at a similar level compared to 5 years ago.
  • PHR has a better debt/assets ratio than last year.
PHR.LS Yearly Shares OutstandingPHR.LS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHR.LS Yearly Total Debt VS Total AssetsPHR.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 23.98 indicates that PHR is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 23.98, PHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that PHR is not too dependend on debt financing.
  • PHR has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. PHR outperforms 96.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 23.98
ROIC/WACCN/A
WACCN/A
PHR.LS Yearly LT Debt VS Equity VS FCFPHR.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • A Current Ratio of 8.40 indicates that PHR has no problem at all paying its short term obligations.
  • The Current ratio of PHR (8.40) is better than 96.97% of its industry peers.
  • PHR has a Quick Ratio of 8.40. This indicates that PHR is financially healthy and has no problem in meeting its short term obligations.
  • PHR has a better Quick ratio (8.40) than 96.97% of its industry peers.
Industry RankSector Rank
Current Ratio 8.4
Quick Ratio 8.4
PHR.LS Yearly Current Assets VS Current LiabilitesPHR.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

0

3. PHR.LS Growth Analysis

3.1 Past

  • PHR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -92.61%.
  • Measured over the past 5 years, PHR shows a small growth in Earnings Per Share. The EPS has been growing by 4.13% on average per year.
EPS 1Y (TTM)-92.61%
EPS 3YN/A
EPS 5Y4.13%
EPS Q2Q%-101.74%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. PHR.LS Valuation Analysis

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
PHR.LS Price Earnings VS Forward Price EarningsPHR.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHR.LS Per share dataPHR.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. PHR.LS Dividend Analysis

5.1 Amount

  • PHR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PHR.LS Fundamentals: All Metrics, Ratios and Statistics

PHAROL SGPS SA

ELI:PHR (4/13/2026, 7:00:00 PM)

0.0778

+0 (+0.65%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)02-23
Earnings (Next)07-23
Inst Owners0.7%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap69.75M
Revenue(TTM)N/A
Net Income(TTM)1.68M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.75%
ROE 1.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)7.12%
ROA(5y)2.27%
ROE(3y)7%
ROE(5y)1.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.4
Quick Ratio 8.4
Altman-Z 23.98
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.61%
EPS 3YN/A
EPS 5Y4.13%
EPS Q2Q%-101.74%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4.61%
EBIT growth 3YN/A
EBIT growth 5Y23.86%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.64%
OCF growth 3YN/A
OCF growth 5YN/A

PHAROL SGPS SA / PHR.LS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PHAROL SGPS SA?

ChartMill assigns a fundamental rating of 2 / 10 to PHR.LS.


What is the valuation status of PHAROL SGPS SA (PHR.LS) stock?

ChartMill assigns a valuation rating of 0 / 10 to PHAROL SGPS SA (PHR.LS). This can be considered as Overvalued.


What is the profitability of PHR stock?

PHAROL SGPS SA (PHR.LS) has a profitability rating of 1 / 10.


Can you provide the financial health for PHR stock?

The financial health rating of PHAROL SGPS SA (PHR.LS) is 7 / 10.